<SEC-DOCUMENT>0001181431-13-060898.txt : 20131127
<SEC-HEADER>0001181431-13-060898.hdr.sgml : 20131127
<ACCEPTANCE-DATETIME>20131127171046
ACCESSION NUMBER:		0001181431-13-060898
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20131121
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20131127
DATE AS OF CHANGE:		20131127

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DYNAVAX TECHNOLOGIES CORP
		CENTRAL INDEX KEY:			0001029142
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				330728374
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34207
		FILM NUMBER:		131248440

	BUSINESS ADDRESS:	
		STREET 1:		2929 SEVENTH STREET
		STREET 2:		SUITE 100
		CITY:			BERKELEY
		STATE:			CA
		ZIP:			94710
		BUSINESS PHONE:		5108485100

	MAIL ADDRESS:	
		STREET 1:		2929 SEVENTH STREET
		STREET 2:		SUITE 100
		CITY:			BERKELEY
		STATE:			CA
		ZIP:			94710
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>rrd396415.htm
<DESCRIPTION>8-K
<TEXT>

<html>
	<head>
		<meta content="text/html; charset=iso-8859-1">
		<title>
			Prepared By R.R. Donnelley Financial -- Form 8-K
		</title>
	</head>
	<body Bgcolor="white">
		<hr Size="4" Noshade Color="#000000" Align="left">
		<div>
			<font Size="1">&nbsp;</font>
		</div>
		<div Align="center">
			<font Face="times New Roman" Size="4" Color="#000000">
				<b>UNITED STATES </b>
			</font>
		</div>
		<div Align="center">
			<font Face="times New Roman" Size="4" Color="#000000">
				<b>SECURITIES AND EXCHANGE COMMISSION</b>
			</font>
		</div>
		<div Align="center">
			<font Face="times New Roman" Size="2" Color="#000000">
				<b>Washington, D.C. 20549</b>
			</font>
		</div>
		<div>
			<font Size="1">&nbsp;</font>
		</div>
		<div Align="center">
			<font Face="times New Roman" Size="5" Color="#000000">
				<b>Form 8-K </b>
			</font>
		</div>
		<div>
			<font Size="1">&nbsp;</font>
		</div>
		<div Align="center">
			<font Face="times New Roman" Size="4" Color="#000000">
				<b>CURRENT REPORT</b>
			</font>
		</div>
		<div Align="center">
			<font Face="times New Roman" Size="4" Color="#000000">
				<b>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</b>
			</font>
		</div>
		<div>
			<font Size="1">&nbsp;</font>
		</div>
		<div Align="center">
			<font Face="times New Roman" Size="3" Color="#000000">
				<b>Date of Report (Date of earliest event reported):&nbsp;&nbsp;11/21/2013 </b>
			</font>
		</div>


		<div>
			<font Size="1">&nbsp;</font>
		</div>
		<div Align="center">
			<font Face="times New Roman" Size="5" Color="#000000">
				<b>Dynavax Technologies Corporation</b>
			</font>
		</div>
		<div Align="center">
			<font Face="times New Roman" Size="2" Color="#000000">
				<b>(Exact name of registrant as specified in its charter)</b>
			</font>
		</div>
		<div>
			<font Size="1">&nbsp;</font>
		</div>
		<div Align="center">
			<font Face="times New Roman" Size="3" Color="#000000">
				<b>Commission File Number:&nbsp;&nbsp;001-34207</b>
			</font>
		</div>
		<div>
			<font Size="1">&nbsp;</font>
		</div>
		<div Align="center">
			<table Cellspacing="0" Cellpadding="0" Width="100%" Border="0">
				<tr>
					<td Valign="bottom" Width="59%" Align="center">
						<div Align="center">
							<font Face="times New Roman" Size="3" Color="#000000">
								<b>Delaware</b>
							</font>
						</div>
					</td>
					<td Valign="bottom" Width="3%">
						<font Face="times New Roman" Size="1">
							&nbsp;&nbsp;
						</font>
					</td>
					<td Valign="bottom" Width="59%" Align="center">
						<div Align="center">
							<font Face="times New Roman" Size="3" Color="#000000">
								<b>33-0728374</b>
							</font>
						</div>
					</td>
				</tr>
				<tr>
					<td Valign="top" Align="center" Width="59%">
						<div Style="margin-left:2%; Text-indent:-2%" Align="center">
							<font Face="times New Roman" Size="2" Color="#000000">
								<b>(State or other jurisdiction of</b>
							</font>
						</div>
					</td>
					<td Valign="bottom" Width="3%">
						<font Face="times New Roman" Size="1">
							&nbsp;&nbsp;
						</font>
					</td>
					<td Valign="bottom" Align="center" Width="59%">
						<div Align="center">
							<font Face="times New Roman" Size="2" Color="#000000">
								<b>(IRS Employer</b>
							</font>
						</div>
					</td>
				</tr>
				<tr>
					<td Valign="top" Align="center" Width="59%">
						<div Style="margin-left:2%; Text-indent:-2%" Align="center">
							<font Face="times New Roman" Size="2" Color="#000000">
								<b>incorporation)</b>
							</font>
						</div>
					</td>
					<td Valign="bottom" Width="3%">
						<font Face="times New Roman" Size="1">
							&nbsp;&nbsp;
						</font>
					</td>
					<td Valign="bottom" Align="center" Width="59%">
						<div Align="center">
							<font Face="times New Roman" Size="2" Color="#000000">
								<b>Identification No.)</b>
							</font>
						</div>
					</td>
				</tr>
			</table>
		</div>
		<div>
			<font Size="1">&nbsp;</font>
		</div>
		<div Align="center">
			<font Face="times New Roman" Size="3" Color="#000000">
				<b>2929 Seventh Street, Suite 100</div><div Align="center">Berkeley, CA 94710-2753</b>
			</font>
		</div>
		<div Align="center">
			<font Face="times New Roman" Size="2" Color="#000000">
				<b>(Address of principal executive offices, including zip code)</b>
			</font>
		</div>
		<div>
			<font Size="1">&nbsp;</font>
		</div>
		<div Align="center">
			<font Face="times New Roman" Size="3" Color="#000000">
				<b>(510) 848-5100</b>
			</font>
		</div>
		<div Align="center">
			<font Face="times New Roman" Size="2" Color="#000000">
				<b>(Registrant&#146;s telephone number, including area code)</b>
			</font>
		</div>
		<div>
			<font Size="1">&nbsp;</font>
		</div>
		<div Align="center">
			<font Face="times New Roman" Size="3" Color="#000000">
				<b> </b>
			</font>
		</div>
		<div Align="center">
			<font Face="times New Roman" Size="2" Color="#000000">
				<b>(Former name or former address, if changed since last report)</b>
			</font>
		</div>
		<div>
			<font Size="1">&nbsp;</font>
		</div>


	<div Align="left">
		<font Face="times New Roman" Size="2" Color="#000000">
			<b>Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:<BR><BR></b>
		</font>
	</div>


	<div Align="left">
		<font Face="times New Roman" Size="2" Color="#000000">
			<b>[&nbsp;&nbsp;]&nbsp;&nbsp;
			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)<BR><BR>
			[&nbsp;&nbsp;]&nbsp;&nbsp;
			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)<BR><BR>
			[&nbsp;&nbsp;]&nbsp;&nbsp;
			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))<BR><BR>
			[&nbsp;&nbsp;]&nbsp;&nbsp;
			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
			</b>
		</font>
	</div>


	<div>
		<font Size="1">&nbsp;</font>
	</div>
	<hr Size="4" Noshade Color="#000000" Align="left">
	<p Style='page-break-before:always'>
	<p Align="center">


		<div>
			<font Size="1">&nbsp;</font>
		</div>
		<div align="left">
			<font Face="times New Roman" Size="2" Color="#000000">
				<b>Item 5.02.&nbsp;&nbsp;&nbsp;&nbsp;Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers</b>
			</font>
		</div>
		<div>
			<font Size="1">&nbsp;</font>
		</div>
		<div  align="left" Style="text-indent:4%">
			<font Face="times New Roman" Size="2" Color="#000000">
				On November 21, 2013, J. Tyler Martin, M.D., informed Dynavax Technologies Corporation that he had decided to resign from the Board of Directors, effective at the end of the year.
			</font>
		</div>
		<div>
			<font Size="1">&nbsp;</font>
		</div>


		<div>
			<font Size="1">&nbsp;</font>
		</div>
		<div align="left">
			<font Face="times New Roman" Size="2" Color="#000000">
				<b>Item 9.01.&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits</b>
			</font>
		</div>
		<div>
			<font Size="1">&nbsp;</font>
		</div>
		<div  align="left" Style="text-indent:4%">
			<font Face="times New Roman" Size="2" Color="#000000">
				(d) Exhibits. <p>The following exhibit is furnished herewith: <p>EX-99.1 Press Release, dated November 27, 2013, titled "Dynavax Announces Resignation of J. Tyler Martin From Board of Directors".
			</font>
		</div>
		<div>
			<font Size="1">&nbsp;</font>
		</div>


	<hr  Size="3" Color="#cceeff" Width="100%" Align="center">
	<p Align="center"><font Size="2">&nbsp;</font>
	<div Align="center">
		<font Face="times New Roman" Size="2" Color="#000000">
			<b>SIGNATURES</b>
		</font>
	</div>
	<div>
		<font Size="1">&nbsp;</font>
	</div>
	<div align="left" Style="text-indent:4%">
		<font Face="times New Roman" Size="2" Color="#000000">
			Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
			duly authorized.
		</font>
	</div>
	<div>
		<font Size="1">&nbsp;</font>
	</div>
	<div>
		<table Cellspacing="0" Cellpadding="0" Width="100%" Border="0">


			<tr>
				<td Valign="top" Colspan="3" Width="53%">
					&nbsp;
				</td>
				<td Valign="bottom" Width="3%">
					&nbsp;
				</td>
				<td>
					&nbsp;
				</td>
				<td Valign="bottom" Width="3%">
					&nbsp;
				</td>
				<td Valign="top" Align="center" Width="3%">
					&nbsp;
				</td>
				<td Valign="bottom" Width="3%">
					&nbsp;
				</td>
				<td Valign="top" Width="53%">
					<div Style="margin-left:2%; Text-indent:-2%">
						<font Face="times New Roman" Size="2" Color="#000000">
							Dynavax Technologies Corporation
						</font>
					</div>
				</td>
			</tr>
			<tr>
				<td>
					&nbsp;
				</td>
			</tr>
			<tr>
				<td>
					&nbsp;
				</td>
			</tr>
			<tr>
				<td Valign="top" Colspan="3" Width="53%">
					<div Style="margin-left:2%; Text-indent:-2%">
						<font Face="times New Roman" Size="2" Color="#000000">
							Date: November 27, 2013
						</font>
					</div>
				</td>
				<td Valign="bottom" Width="3%">
					&nbsp;
				</td>
				<td>
					&nbsp;
				</td>
				<td Valign="bottom" Width="3%">
					&nbsp;
				</td>
				<td Valign="top" Align="center" Width="3%">
					<div Align="center">
						<font Face="times New Roman" Size="2" Color="#000000">
							By:
						</font>
					</div>
				</td>
				<td Valign="bottom" Width="3%">
					&nbsp;
				</td>
			<td Valign="top" Width="53%">
				<div Style="margin-left:2%; Text-indent:-2%">
					<font Face="times New Roman" Size="2" Color="#000000">
						/s/&nbsp;&nbsp;&nbsp;&nbsp;Michael Ostrach</font>
				</div>
				<hr Noshade Align="left" Color="#000000">
			</td>
		</tr>
		<tr>
			<td>
				&nbsp;
			</td>
			<td Valign="bottom" Width="3%">
				&nbsp;
			</td>
			<td>
				&nbsp;
			</td>
			<td Valign="bottom" Width="3%">
				&nbsp;
			</td>
			<td>
				&nbsp;
			</td>
			<td Valign="bottom" Width="3%">
				&nbsp;
			</td>
			<td>
				&nbsp;
			</td>
			<td Valign="bottom" Width="3%">
				&nbsp;
			</td>
			<td Valign="bottom" Width="53%">
				<div Style="margin-left:2%; Text-indent:-2%">
					<font Face="times New Roman" Size="2" Color="#000000">
						Michael Ostrach</font>
				</div>
			</td>
		</tr>
		<tr>
			<td>
				&nbsp;
			</td>
			<td Valign="bottom" Width="3%">
				&nbsp;
			</td>
			<td>
				&nbsp;
			</td>
			<td Valign="bottom" Width="3%">
				&nbsp;
			</td>
			<td>
				&nbsp;
			</td>
			<td Valign="bottom" Width="3%">
				&nbsp;
			</td>
			<td>
				&nbsp;
			</td>
			<td Valign="bottom" Width="3%">
				&nbsp;
			</td>
			<td Valign="bottom" Width="53%">
				<div>
					<font Face="times New Roman" Size="2" Color="#000000">
						Vice President
					</font>
				</div>
			</td>
		</tr>
		<tr>
			<td>
				&nbsp;
			</td>
		</tr>
		<tr>
			<td>
				&nbsp;
			</td>
		</tr>


	</table>
</div>


		<p Style='page-break-before:always'>
		<hr  Size="3" Color="#cceeff" Width="100%" Align="center">
		<p Align="center"><font Size="2">&nbsp;</font>
		<div Align="center">
			<font Face="times New Roman" Size="2" Color="#000000">
			<b>EXHIBIT INDEX</b>
		</font>
		</div>
		<div>
			&nbsp;
		</div>
		<div Align="center">
			<table Cellspacing="0" Cellpadding="0" Width="100%" Border="0">
				<tr>
					<td Valign="top" Align="left">
						<div Align="left">
							<font Face="times New Roman" Size="2" Color="#000000">
								<b>Exhibit&nbsp;No.</b>
							</font>
						</div>
						<hr Size="2" Noshade Width="48" Color="#000000">
					</td>
					<td Valign="top" Width="3%" Align="left">
						<font Face="times New Roman" Size="2">&nbsp;&nbsp;</font>
					</td>
					<td Valign="top" Width="100%" Align="left">
						<div>
							<font Face="times New Roman" Size="2" Color="#000000">
								<b>Description</b></font>
						</div>
						<hr Size="2" Noshade Width="73" Align="left" Color="#000000">
					</td>
				</tr>


				<tr>
					<td Valign="top" Align="left">
						<div Align="top">
							<font Face="times New Roman" Size="1" Color="#000000">
								EX-99.1
							</font>
						</div>
					</td>
					<td Valign="top" Width="3%" Align="left">
						<font Face="times New Roman" Size="2">&nbsp;&nbsp;</font>
					</td>
					<td Valign="top" Width="100%" Align="left">
						<div>
							<font Face="times New Roman" Size="2" Color="#000000">
								Dynavax Announces Resignation of J. Tyler Martin From Board of Directors. </font>
						</div>
					</td>
				</tr>


		</table>
			</div>


	</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>rrd396415_40237.htm
<DESCRIPTION>DYNAVAX ANNOUNCES RESIGNATION OF J. TYLER MARTIN FROM BOARD OF DIRECTORS.
<TEXT>
<HTML>
<HEAD>
<TITLE>Dynavax Technologies</TITLE>
</HEAD>
<BODY LINK="#0000ff">
<B><FONT SIZE=2 COLOR="#008080"><FONT SIZE=2 COLOR="#008080"><P>Dynavax Technologies</P>
<P>2929 Seventh Street, Suite 100</P>
<P>Berkeley, CA 94710</P>
</FONT></FONT><FONT FACE="Arial"></B></FONT>
<P ALIGN="CENTER"><CENTER><TABLE CELLSPACING=0 BORDER=0 WIDTH=579 DIR="LTR">
<TR><TD WIDTH="50%" VALIGN="TOP">
<B><FONT FACE="Arial" SIZE=3><FONT FACE="Arial" SIZE=3><P>Contact:</B></FONT></FONT></TD>
<TD WIDTH="3%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="47%" VALIGN="TOP">&nbsp;</TD>
</TR>
<TR><TD WIDTH="50%" VALIGN="TOP">
<FONT FACE="Arial" SIZE=3><FONT FACE="Arial" SIZE=3><P>Michael Ostrach</FONT></FONT></TD>
<TD WIDTH="3%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="47%" VALIGN="TOP">&nbsp;</TD>
</TR>
<TR><TD WIDTH="50%" VALIGN="TOP" HEIGHT=28>
<FONT FACE="Arial" SIZE=3><FONT FACE="Arial" SIZE=3><P>Vice President and Chief Business Officer </FONT></FONT></TD>
<TD WIDTH="3%" VALIGN="TOP" HEIGHT=28><P></P></TD>
<TD WIDTH="47%" VALIGN="TOP" HEIGHT=28><P></P></TD>
</TR>
<TR><TD WIDTH="50%" VALIGN="TOP" HEIGHT=9>
<FONT FACE="Arial" SIZE=3><FONT FACE="Arial" SIZE=3><P>510-665-7257</FONT></FONT></TD>
<TD WIDTH="3%" VALIGN="TOP" HEIGHT=9><P></P></TD>
<TD WIDTH="47%" VALIGN="TOP" HEIGHT=9><P></P></TD>
</TR>
<TR><TD WIDTH="50%" VALIGN="TOP" HEIGHT=9>
<FONT FACE="Arial" SIZE=3><FONT FACE="Arial" SIZE=3><P>mostrach@dynavax.com</FONT></FONT></TD>
<TD WIDTH="3%" VALIGN="TOP" HEIGHT=9><P></P></TD>
<TD WIDTH="47%" VALIGN="TOP" HEIGHT=9><P></P></TD>
</TR>
</TABLE>
</CENTER></P>
<B><FONT FACE="Arial" SIZE=3><FONT FACE="Arial" SIZE=3><P ALIGN="CENTER">DYNAVAX ANNOUNCES RESIGNATION OF J. TYLER MARTIN FROM BOARD OF DIRECTORS</P>
</B><P>BERKELEY, CA&nbsp;--&nbsp;11/27/13&nbsp;--&nbsp;Dynavax Technologies Corporation&nbsp;(NASDAQ: DVAX)&nbsp;announced today that J. Tyler Martin, M.D. plans to resign from the Board of Directors, effective at the end of the year.&nbsp; Dr. Martin, a director of the Company since 2010,&nbsp;decided to resign to devote more time to his other professional responsibilities.&nbsp; Dr. Martin is Founder and Chief Executive Officer of Great Plains Biotechnology, a strategic advisory group for biotechnology companies and investors.&nbsp;</P>
<P>&quot;We thank Tyler for his leadership, expertise and contributions to Dynavax, both as a colleague on the Board and as our former President and Chief Medical Officer,&quot; said Arnold Oronsky, Ph.D., Chairman of Dynavax.</P>
<P>Dr. Martin added, &quot;I am proud to have worked with Dynavax's other Board members and its employees and collaborators. With a new CEO and a path forward established for HEPLISAV&trade; in the US, Dynavax is well on its way to becoming a successful company that will bring benefit to many people.&quot;</P>
<B><P>About Dynavax</P>
</B>
<P>Dynavax, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases and cancer. The Company's lead product candidate is HEPLISAV, a Phase 3 investigational adult hepatitis B vaccine. For more information visit&nbsp;www.dynavax.com.</P>
<P>&nbsp;</P>
</FONT></FONT></BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
